Matthias von Herrath

Company: Novo Nordisk

Job title: VP & Senior Medical Officer

Seminars:

Panel Discussion: Improving Strategies for Long Term Graft Acceptance of Allogeneic Therapies 11:30 am

Exploring the regulations around how cells can be modified How much do you need to modify cells? Moving towards improving immune modulatory regimens that don’t require long-term immune suppressionRead more

day: Day Two